FGF19 and metabolic dysfunction-associated steatohepatitis: Although we observed striking alterations in FGF19 signaling, associated with NASH-HCC on the one hand and significant changes in BA homeostasis associated with fibrosis on the other hand, it remains unclear whether these mechanisms occur independently or synergistically during hepatocarcinogenesis.